Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc. financial statements

Windtree Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 0EODHD
Net income−USD 5.49MEODHD
Cash and equivalentsUSD 1.78MEODHD
Total debtUSD 1.82MEODHD

Windtree Therapeutics, Inc. financials on 6ix · Windtree Therapeutics, Inc. on 6ix